Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE1404.60-37.45 (-2.6 %)

PREV CLOSE ( ) 1442.05

OPEN PRICE ( ) 1497.75

BID PRICE (QTY) 1404.40 (5)

OFFER PRICE (QTY) 1415.80 (1)

VOLUME 759

TODAY'S LOW / HIGH ( )1390.00 1497.75

52 WK LOW / HIGH ( )962.7 2744.4

NSE1414.90-21 (-1.46 %)

PREV CLOSE( ) 1435.90

OPEN PRICE ( ) 1484.00

BID PRICE (QTY) 1410.70 (1)

OFFER PRICE (QTY) 1414.00 (5)

VOLUME 5531

TODAY'S LOW / HIGH( ) 1379.90 1490.00

52 WK LOW / HIGH ( )957 2755.1

Chairman	Dhananjay Mungale
Managing Director	Rahul J Nachane
Company Secretary	Pallavi Pednekar
Non Executive Director	Ajita Nachane
Non Executive Independent Director	Jayaram Sitaram Milind V Shinde Sarala Menon
Whole Time Director	Rajesh N Lawande

Incorporation Year : 1981

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East) Mumbai,
Maharashtra-400057 .

Phone : 022 40842222

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE